Jump to Main Content

Newsroom

Submit
Reset

ASH Honors 2026 Leaders in Hematology With Most Prestigious Awards

Jun 23
2026

Eleven hematologists recognized for advancing research and care for patients with blood diseases (WASHINGTON, June 23, 2026) — The American Society of Hematology (ASH) is recognizing 11 distinguished hematologists with its most prestigious aw...

Read more

ASH Statement on NIH Funding in FY 2027 House Appropriations Bill and OMB Proposal

Jun 12
2026

The House Appropriations bill provides continued support for NIH, but the Senate needs to do more (WASHINGTON—June 12, 2026) – The American Society of Hematology (ASH) thanks the U.S. House of Representatives for rejecting the Trump admi...

Read more

Stem Cell Transplantation More Cost-Effective than Gene Therapy for Sickle Cell Disease

Jun 02
2026

Advancements in stem cell transplantation further undermine cost-effectiveness of gene therapy, support additional 66% to 71% price reduction (WASHINGTON, June 2, 2026) — Stem cell transplantation is the most cost-effective option for long-term...

Read more

New Approach Could Lead to Earlier Diagnosis of Iron Deficiency in Children Aged 5-14 Years

May 20
2026

Higher ferritin threshold may identify earlier, treatable cases in children (WASHINGTON, May 20, 2026) – Many cases of iron deficiency in school-aged children could be diagnosed earlier, according to a new study published in Blood Red Cells & I...

Read more

ASH Funds 10 Treating Fairly Research Awards to Protect Critical Hematology Research

Apr 21
2026

Award supports independent investigators in hematology whose research confronts inequities in blood diseases amid shifting federal funding priorities (WASHINGTON, April 21, 2026) — In an effort to counteract federal cuts to health equity outcom...

Read more

Individuals Living with Sickle Cell Disease in Sub-Saharan Africa Face Substantial Barriers to Managing Their Condition

Apr 14
2026

Patients in sub-Saharan Africa less likely to know details about their disease variant, use over-the-counter medications, and go to the hospital for pain crises (WASHINGTON — Apr. 14, 2026) — Individuals living with sickle cell disease in sub-Sahara...

Read more

ASH and ISTH Guidelines on Anticoagulant Prophylaxis in Pediatric VTE

Apr 08
2026

Recommendations outline best practices for preventing increasingly common, life-threatening complication in children (WASHINGTON, Apr. 8, 2026) — The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (IS...

Read more

ASH Statement on Proposed FY27 Budget Cuts to the National Institutes of Health

Apr 03
2026

The proposed 12.3% reduction in funding would impede progress in research for blood disorders (WASHINGTON—April 3, 2026) – The Trump Administration published details of the President’s Fiscal Year 2027 Budget Request, which includes a proposed cut o...

Read more

ASH Publishes Clinical Practice Guidelines on Diagnosis and Management of Severe and Very Severe Acquired Aplastic Anemia

Apr 01
2026

Recommendations outline best practices for diagnosing and managing the rare and life-threatening condition in children and adults (WASHINGTON — Apr. 1, 2026) — The American Society of Hematology (ASH) released guidelines on the diagnosis and manageme...

Read more

Higher Burnout Rates Among Physicians Who Treat Sickle Cell Disease

Mar 12
2026

New data show 60% of sickle cell physicians report burnout (WASHINGTON — Mar. 12, 2026) — Hematology-oncology trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle c...

Read more